Comparison of Conservative Treatment and Thymectomy on Myasthenia Gravis Outcome.
systematic_review · Level I
Where this comes from
- Record sourced from PubMed, PMID 28148454.
- Also identified by DOI 10.1016/j.athoracsur.2016.08.052.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A systematic review of the literature was performed to compare long-term outcomes of thymectomy and medical treatment for generalized myasthenia gravis (MG). A Medline search through June 2015 resulted in 71 studies, 27 of which were selected (10,140 patients: 5,275 thymectomies, 4,865 medication). The pooled proportion of remission with thymectomy was 0.31 (95% CI, 0.25-0.37), with conservative treatment it was 0.15 (95% CI, 0.12-0.18). The odds ratio (OR) of remission with thymectomy in comparison with medication alone was 2.44 (95% CI, 1.91-3.12) overall and according to medication type and remission definitions. Thymectomy is superior to conservative treatment with solely medication on remission in MG.
Medical subject headings
- Conservative Treatment
- Myasthenia Gravis
- Thymectomy